Does circadian rhythm disruption induced by light-at-night has beneficial effect of melatonin on sciatic nerve injury?

[1]  N. Demir,et al.  Comparison of the beneficial effect of melatonin on recovery after cut and crush sciatic nerve injury: a combined study using functional, electrophysiological, biochemical, and electron microscopic analyses , 2013, Child's Nervous System.

[2]  N. G. Tolosa de Talamoni,et al.  New perspectives in melatonin uses. , 2012, Pharmacological research.

[3]  S. Cuzzocrea,et al.  Antiinflammatory Activity of Melatonin in Central Nervous System , 2010, Current neuropharmacology.

[4]  S. Scheff,et al.  Melatonin-analog, β-methyl-6-chloromelatonin, supplementation in spinal cord injury , 2010, Brain Research.

[5]  P. Pévet,et al.  Endogenous melatonin provides an effective circadian message to both the suprachiasmatic nuclei and the pars tuberalis of the rat , 2009, Journal of pineal research.

[6]  E. Mazzon,et al.  Effects of combination of melatonin and dexamethasone on secondary injury in an experimental mice model of spinal cord trauma , 2007, Journal of pineal research.

[7]  D. Acuña-Castroviejo,et al.  Cellular mechanisms involved in the melatonin inhibition of HT‐29 human colon cancer cell proliferation in culture , 2007, Journal of pineal research.

[8]  Z. Lu,et al.  Melatonin inhibits fatty acid-induced triglyceride accumulation in ROS17/2.8 cells: implications for osteoblast differentiation and osteoporosis. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

[9]  R. Tubbs,et al.  Neuroprotective effects of high-dose vs low-dose melatonin after blunt sciatic nerve injury , 2007, Child's Nervous System.

[10]  M. Sánchez-Hidalgo,et al.  Melatonin and lipid uptake by murine fibroblasts: clinical implications. , 2006, Neuro endocrinology letters.

[11]  S. Çelik,et al.  Dose-dependent neuroprotective effects of melatonin on experimental spinal cord injury in rats. , 2005, Surgical neurology.

[12]  G. Chazot,et al.  Pharmacokinetics of melatonin in man after intravenous infusion and bolus injection , 2004, European Journal of Clinical Pharmacology.

[13]  Madhur Gupta,et al.  Neuroprotective role of melatonin in oxidative stress vulnerable brain. , 2003, Indian journal of physiology and pharmacology.

[14]  A. Oliveira,et al.  Neuroprotective action of melatonin on neonatal rat motoneurons after sciatic nerve transection , 2002, Brain Research.

[15]  D. Acuña-Castroviejo,et al.  Free Radical‐Mediated Molecular Damage , 2001, Annals of the New York Academy of Sciences.

[16]  J. Lue,et al.  Melatonin attenuates neuronal NADPH-d/NOS expression in the hypoglossal nucleus of adult rats following peripheral nerve injury , 2000, Brain Research.

[17]  L. Facci,et al.  Excitotoxicity, Oxidative Stress, and the Neuroprotective Potential of Melatonin , 1999, Annals of the New York Academy of Sciences.

[18]  Guido Stoll,et al.  Nerve Injury, Axonal Degeneration and Neural Regeneration: Basic Insights , 1999, Brain pathology.

[19]  R. Reiter,et al.  Melatonin and tryptophan derivatives as free radical scavengers and antioxidants. , 1999, Advances in experimental medicine and biology.

[20]  R. Reiter.  Oxidative damage in the central nervous system: protection by melatonin , 1998, Progress in Neurobiology.

[21]  J. Vane,et al.  Anti-inflammatory drugs and their mechanism of action , 1998, Inflammation Research.

[22]  W. Wąsowicz,et al.  Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. , 1993, Clinical chemistry.

[23]  S. Mackinnon,et al.  Functional Evaluation of Complete Sciatic, Peroneal, and Posterior Tibial Nerve Lesions in the Rat , 1989, Plastic and reconstructive surgery.

[24]  A. Mason,et al.  Serum melatonin after a single aqueous subcutaneous injection in Syrian hamsters. , 1986, Neuroendocrinology.

[25]  R. Wiggins,et al.  Effect of Reactive Oxygen Species on Myelin Membrane Proteins , 1985, Journal of neurochemistry.

[26]  J. Arendt,et al.  Plasma concentrations of melatonin in man following oral absorption of different preparations. , 1985, British journal of clinical pharmacology.

[27]  H R Lieberman,et al.  Bioavailability of oral melatonin in humans. , 1984, Neuroendocrinology.

[28]  E. Hall,et al.  Effects of intravenous methylprednisolone on spinal cord lipid peroxidation and Na+ + K+)-ATPase activity. Dose-response analysis during 1st hour after contusion injury in the cat. , 1982, Journal of neurosurgery.

[29]  J. Vriend,et al.  The half-life of melatonin elimination from rat plasma. , 1981, Endocrinology.

[30]  H. Weissbach,et al.  The fate of melatonin in animals. , 1961, The Journal of biological chemistry.